Kyverna Therapeutics presented updated Phase 1 trial data showing that a single dose of miv-cel, a CAR T-cell therapy, provides sustained clinical benefits in patients with progressive multiple sclerosis (PMS). The therapy demonstrated robust penetration into the central nervous system, improved disability scores, and eliminated the need for chronic immunotherapies in most patients, with benefits lasting over two years in one case. Safety was favorable with no severe side effects reported. Kyverna plans to update its development strategy by early 2027, aiming to advance miv-cel as a novel treatment for PMS under its RMAT designation.
Kyverna Therapeutics' update on miv-cel clinical data comes amid a Health sector where only 19 of 150 US stocks rose today. For readers following Health stocks, here is Pluang's market snapshot as of Oct 23, 2026 21:32 WIB: Tango Therapeutics Inc. (TNGX) dropped 17.81% to USD 22.95 with 100% buy orders and a typical hold time of 2 days; Nuwellis Inc (NUWE) fell 9.86% to USD 0.44 with 100% buy orders and a 29-day hold; Inovio Pharmaceuticals Inc (INO) gained 8.05% to USD 0.91 with 73% sell orders and a 43-day hold time.
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
The global computed tomography (CT) market is undergoing significant innovation driven by photon-counting technology, AI integration, mobile imaging, and point-of-care applications. These advancements are enhancing image quality, workflow efficiency,...
